| View |
|
BR-536
|
Human Plasma Coagulation Factor VIII
|
Emoclot
|
500 IU
|
Lyophilized Powder for Injection (IV)
|
-
|
Kedrion S.p.A
|
Italy
|
Initial (Variation)
|
06 October 2022
|
06 October 2027
|
| View |
|
BR-539
|
Human Coagulation Factor IX
|
Aimafix
|
500IU
|
Lyophilized Powder For Injection
|
Plasma Fraction for Specific Use
|
Kedrion S.P.A
|
Italy
|
Renewal
|
04 April 2019
|
14 January 2029
|
| View |
|
BR-540
|
Botulinum Toxin Type A
|
Dysport
|
500 Units
|
Lyophilized Powder for Injection (IM/SC)
|
500 U Lyophilized Powder for Injection (IM/SC)
|
IPSEN Biopharm Ltd.
|
United Kingdom
|
Renewal
|
01 August 2023
|
14 January 2029
|
| View |
|
BR-567
|
Hepatitis B Vaccine ( rDNA )
|
Genvac-B
|
10mcg/0.5mL
|
Suspension For Injection(IM)
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
-
|
17 January 2022
|
17 January 2025
|
| View |
|
BR-568
|
Hepatitis B vaccine (rDNA)
|
None
|
20 mcg/mL
|
Suspension for Injection(IM) (Multidose) (Adult)
|
-
|
Serum Institue of India Ltd.
|
India
|
-
|
29 June 2021
|
17 January 2025
|
| View |
|
BR-572
|
BCG Vaccine
|
None
|
None
|
Freeze-Dried Powder For Injection (I.D.)
|
-
|
Serum Institute of India Ltd.
|
India
|
-
|
08 September 2020
|
17 February 2025
|
| View |
|
BR-574
|
Hepatitis B vaccine (rDNA)
|
Genvac-B
|
20mcg/mL
|
Suspension For Injection (IM) Single Dose (Adult)
|
-
|
Serum Institue of India Pvt. Ltd.
|
India
|
-
|
13 April 2022
|
11 May 2025
|
| View |
|
BR-589
|
Hepatitis B Vaccine ( rDNA)
|
None
|
10mcg/0.5mL
|
Suspension for Injection (IM) (Pediatric)
|
-
|
Serum Institute of India Private Limited
|
India
|
-
|
26 February 2021
|
05 October 2025
|
| View |
|
BR-591
|
Tuberculin Purified Protein Derivative
|
None
|
2TU/0.1mL
|
Solution For Injection (Id)
|
Diagnostic Agent
|
Arkray Healthcare Pvt. Ltd.
|
India
|
Renewal (Variation)
|
02 August 2022
|
28 October 2027
|
| View |
|
BR-596
|
Bacillus Calmette-Guerin (BCG) Vaccine
|
None
|
250 mcg
|
Freeze-dried Powder for Intradermal Injection
|
Immunostimulant
|
Chengdu Institute of Biological Products
|
China
|
Renewal
|
24 August 2023
|
10 March 2028
|
| View |
|
BR-599
|
Human Tetanus Immunoglobulin
|
Tetagam P
|
250 I.U. (100 mg to 170 mg)/mL
|
Solution For Injection (I.M.)
|
-
|
CSL Behring GmbH
|
Germany
|
-
|
28 October 2021
|
12 September 2026
|
| View |
|
BR-602
|
Human Papillomavirus Vaccine (Types 6, 11, 16 And 18) (Recombinant Adsorbed
|
Gardasil
|
Each 0.5 mL contains: Type 6 Ll protein 20 ug
Type 11 L1 protein 40 ug
Type 16 L1 protein 40 ug
Type 18 L1 protein 20 ug
|
Suspension for Injection IM
|
Vaccine
|
Merck Sharp & Dohme Corp.
|
United States of America
|
Renewal
|
03 October 2023
|
19 October 2028
|
| View |
|
BR-603
|
Human Papillomavrius Vaccine [Types 6, 11, 16, 18] (Recombinant, Adsorbed)
|
Gardasil
|
0.5mL (See Reverse Dosage)
|
Suspension for Injection IM
|
Vaccine
|
Merck Sharp & Dohme Corp.
|
United States of America
|
Renewal
|
30 January 2020
|
19 October 2028
|
| View |
|
BR-615
|
Rotavirus Vaccine, Live
|
Rotateq
|
2mL
|
Solution For Oral Administration - Single Dose
|
Vaccines
|
Merck Sharp & Dohme Corp
|
United States of America
|
Renewal
|
08 September 2024
|
02 August 2029
|
| View |
|
BR-616
|
Human Papillomavirus Vaccine [Types 16, 18]
(Recombinant, Adjuvanted, Adsorbed)
|
Cervarix
|
0.5 mL
|
Suspension For Injection (I.M.)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
16 December 2021
|
07 September 2026
|
| View |
|
BR-619
|
Tetanus Toxoid Adsorbed
|
IMATET
|
40 IU/0.5 ML
|
SUSPENSION FOR INJECTION (IM)
|
VACCINE
|
AMSON VACCINES & PHARMA (PVT.) LTD.
|
Pakistan
|
Renewal
|
05 August 2022
|
24 August 2027
|
| View |
|
BR-629
|
Purified Vero Cell Rabies Vaccine
|
Abhayrab
|
2.5 IU/0.5 mL
|
Freeze Dried Powder For Injection (I.M./I.D.)
|
Vaccine
|
Human Biologicals Institute (A Division of Indian Immunologicals Limited)
|
India
|
Automatic Renewal
|
22 December 2022
|
21 February 2028
|
| View |
|
BR-630
|
Diphtheria-Tetanus Toxoids And Acellular Pertussis Vaccine, Adsorbed
|
Boostrix
|
Formulation: Each dose (0.5 mL) contains:
Diphtheria toxoid -2.5LF Tetanus toxoid-5.0 Lf Pertussis toxoid-8 mcg Filamentous hemagglutinin (FHA)-8 mcg Pertactin (PRN or 69 kDa OMP)-2.5 mcg
|
0.5 mL Suspension for Injection (IM) - 2PE (See reverse for Formulation)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
-
|
19 February 2021
|
09 September 2025
|
| View |
|
BR-632
|
Epoetin alfa (Recombinant Human Erythropoietin)
|
Epotin
|
4000 IU/ mL
|
Solution for Injection (IV/SC)
|
Other Antianemic Preparations
|
Gulf Pharmaceuticals Industries (Julphar)
|
UAE
|
Automatic Renewal
|
10 August 2021
|
19 August 2026
|
| View |
|
BR-637
|
Epoetin Alfa
|
Epokine
|
4000 IU/mL
|
Solution For Injection (IV/SC)
|
Anti-anaemic Preparations
|
HK inno.N Corporation
|
Korea
|
Automatic Renewal
|
07 January 2022
|
20 October 2026
|